September 24, 2022, Revolution Cancer International Molecular Tumor Board- NOVARTIS, MET, mdm2, MSI

Поделиться
HTML-код
  • Опубликовано: 19 ноя 2024

Комментарии • 1

  • @revolutioncancer6610
    @revolutioncancer6610  2 года назад

    I misspoke at the beginning when I said pluvicto was in pancreatic. Obviously, it's in prostate cancer and we talk about that extensively later in the talk when we present the pluvicto data while talking about a stage 4 prostate cancer patient.